Antonio
González Martín
Consultor Médico
![Foto de Antonio](/img/nophoto.png)
![Foto de Hospital Universitario La Paz](/img/noimage_org.png)
Hospital Universitario La Paz
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario La Paz (19)
2023
2022
2021
-
Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study
The Lancet. Oncology, Vol. 22, Núm. 5, pp. 609-619
-
Management of advanced ovarian cancer in Spain: an expert Delphi consensus
Journal of Ovarian Research, Vol. 14, Núm. 1
-
SEOM clinical guideline in ovarian cancer (2020)
Clinical and Translational Oncology, Vol. 23, Núm. 5, pp. 961-968
2020
-
Primary results from CECILIA, a global single-arm phase II study evaluating bevacizumab, carboplatin and paclitaxel for advanced cervical cancer
Gynecologic Oncology, Vol. 159, Núm. 1, pp. 142-149
2018
-
Correction to: SEOM clinical guidelines for endometrial cancer (2017) (Clinical and Translational Oncology, (2018), 20, 1, (29-37), 10.1007/s12094-017-1809-9)
Clinical and Translational Oncology
-
Erratum to: Recommendations for biomarker testing in epithelial ovarian cancer: a National Consensus Statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology (Clinical and Translational Oncology, (2018), 20, 3, (274-285), 10.1007/s12094-017-1719-x)
Clinical and Translational Oncology
-
Recommendations for biomarker testing in epithelial ovarian cancer. A national consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology
Revista Espanola de Patologia
-
Recommendations for biomarker testing in epithelial ovarian cancer: a National Consensus Statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology
Clinical and Translational Oncology, Vol. 20, Núm. 3, pp. 274-285
-
SEOM clinical guidelines for endometrial cancer (2017)
Clinical and Translational Oncology, Vol. 20, Núm. 1, pp. 29-37
2017
-
A definition for aggressive disease in patients with HER-2 negative metastatic breast cancer: an expert consensus of the Spanish Society of Medical Oncology (SEOM)
Clinical and Translational Oncology, Vol. 19, Núm. 5, pp. 616-624
-
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
Obstetrical and Gynecological Survey
2016
-
Nab-Paclitaxel in metastatic breast cancer: Defining the best patient profile
Current Cancer Drug Targets, Vol. 16, Núm. 5, pp. 415-428
-
Niraparib maintenance therapy in platinum-sensitive, recurrent ovarian cancer
New England Journal of Medicine, Vol. 375, Núm. 22, pp. 2154-2164
-
SEOM Clinical Guideline in ovarian cancer (2016)
Clinical and Translational Oncology, Vol. 18, Núm. 12, pp. 1206-1212
2015
-
SEOM guidelines for cervical cancer
Clinical and Translational Oncology, Vol. 17, Núm. 12, pp. 1036-1042
2013
-
GEICO (Spanish Group for Investigation on Ovarian Cancer) treatment guidelines in ovarian cancer 2012
Clinical and Translational Oncology, Vol. 15, Núm. 7, pp. 509-525
2011
-
Feasibility of a modified outpatient regimen of intravenous/intraperitoneal chemotherapy in optimally debulked stage III ovarian cancer patients A GEICO study
International Journal of Gynecological Cancer, Vol. 21, Núm. 6, pp. 1048-1055